What is the prognosis for patients with NRAS-mutant cancers?
The prognosis for patients with NRAS-mutant cancers varies depending on the type and stage of cancer. Generally, NRAS mutations are associated with a more aggressive disease course and poorer outcomes in melanoma and AML. However, advancements in immunotherapy and combination treatments are improving survival rates for some patients.
